Florida Company Settles Case Involving Select Agent Regulations
On June 29, 2018, a Florida company agreed to pay $100,000 to resolve its liability for violating the select agent regulations. OIG alleged that the laboratory violated the select agent regulations when it transferred a select toxin to an entity that was not registered to possess, use, or transfer that toxin, and the company did not obtain prior authorization from the Centers for Disease Control and Prevention for this transfer. OIG contends this conduct subjects the company to civil money penalties under the Public Health Security and Bioterrorism Preparedness and Response Act, 42 U.S.C. 262a(i), and 42 C.F.R. 1003.102(b)(16).
- Date:June 29, 2018
- CMP and Affirmative Exclusions